Navigation Links
Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
Date:11/27/2012

SDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is leveraging a mature therapeutic platform based on technology that has been developed over 20 years. Regulus works with a broad network of academic collaborators and leverages the oligonucleotide drug discovery and development expertise of its founding companies, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Isis Pharmaceuticals (NASDAQ:ISIS). Regulus is advancing microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis, hepatitis C and metabolic diseases. Regulus has formed strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi and a research collaboration with Biogen Idec.

For more information, please visit http://www.regulusrx.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Regulus' expectations regarding future therapeutic and commercial potential of Regulus' business plans, technologies and intellectual property related to microRNA therapeutics being discovered and developed by Regulus.  Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "intends," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Regulus' current expectations and involve assumptions that may never materialize or may prove to be incorrect.  Actual results and the timing of events could differ materially from those
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
2. Regulus Therapeutics Appoints Bruce Carter to its Board of Directors
3. Regulus Files Registration Statement for Proposed Initial Public Offering
4. Regulus to Present at the Lazard Capital Markets Healthcare Conference
5. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
6. Elsevier / MEDai Appoints Tom Zajac as New President
7. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
8. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
9. BioStorage Technologies Appoints New Member to Board of Directors
10. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
11. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... 15, 2014 The Microcompetition with Foreign DNA ... One of these latent viruses is the Epstein Barr Virus ... Rheumatoid arthritis (RA) is a chronic inflammatory disease that destroys ... found that RA patients have high concentrations of EBV DNA ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of Notched ... tinnitus. Patients listen to sound therapy that is tailor-made ... weeks to months, their tinnitus volume decreases. , AudioNotch has ... and Notched White Noise. Now, AudioNotch is pleased to announce ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... team of physicists at UC Santa Barbara has seen the ... high- and low-frequency laser beams at a semiconductor, the researchers ... then smashed back into the cores they left behind. This ... in the current issue of the science journal Nature ...
... March 30, 2012  Human Pheromone Sciences, Inc. (EROX) ("HPS" or ... Company filed a Form 15 with the SEC in order ... under the Securities Exchange Act of 1934.  Upon this voluntary ... and current reports with the SEC, including Forms 10-K, 10-Q ...
... 28, 2012   Luminex Corporation  (NASDAQ: ... vice president of Biodefense will present at ... taking place March 27-29, 2012 in Denver, Colorado. The meeting ... Joint Program Executive Office for Chemical and ...
Cached Biology Technology:UCSB Physicists mix 2 lasers to create light at many frequencies 2UCSB Physicists mix 2 lasers to create light at many frequencies 3Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration 2Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration 3Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration 4Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration 5Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference 2Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference 3Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference 4
(Date:4/17/2014)... April 17 In the most densely forested and ... reflect two centuries of human needs, values and practices. ... clearing forests for agriculture and development, have set the ... U.S. Forest Service study reports. , The report ... and management needs in the Northern United States ...
(Date:4/17/2014)... peppers. Information about archaeological remains of ancient chili peppers ... of words for chili peppers in ancient dialects helped ... the value of multi-proxy data analysis. Their results are ... presented in a special feature issue of the ... plant and animal domestication edited by Dolores Piperno, staff ...
(Date:4/17/2014)... new modeling study suggests that fish consumption advisories ... exposure to long-lived contaminants like persistent organic pollutants ... team of researchers including University of Toronto Scarborough ... looks at how different levels of environmental contamination, ... of chemicals in the body influenced exposure in ...
Breaking Biology News(10 mins):Five anthropogenic factors that will radically alter northern forests in 50 years 2Five anthropogenic factors that will radically alter northern forests in 50 years 3Chickens to chili peppers 2Chickens to chili peppers 3Fish consumption advisories fail to cover all types of contaminants 2
... is not a word typically associated with trees; they can take ... week of Feb. 1 in the Proceedings of the National ... Eastern United States are growing faster than they have in the ... an ecosystem is responding to ,climate change. For more than ...
... Calif. Biologists have known for long that ecology, ... significant role in forming new species and in modifying ... shapes evolution. The environment defines a template and the ... fit that template. Some specialized theory, ...
... Feb. 1, 2010) -- Mapping DNase I hypersensitive ... genetic regulatory elements such as promoters, enhancers, silencers, insulators, ... to provide access for transcription factors, are selectively digested ... blots to then identify these hypersensitive sites. In ...
Cached Biology News:Ecologists discover forests are growing faster 2Ecologists discover forests are growing faster 3Evolution impacts environment, challenging traditionally held view, UC Riverside study finds 2Evolution impacts environment, challenging traditionally held view, UC Riverside study finds 3High-throughput analysis of gene regulation, DNA synthesis in Cold Spring Harbor Protocols 2
Automated -80° C sample library for microplates and cryotube racks in SBS format; for integration into automated processes....
... PROTECT FROM MOISTURE. AVOID FREEZE/THAW CYCLES. This ... in vitro by DNA affinity-mediated ... anti-histone-facilitated detection. In this assay, mono- and ... proteins. Anti-Histone 3 (H3) biotin-labeled antibody then ...
OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture...
OmniSlide Heated Wash Module. 2 independent chambers with precise temperature control from ambient of 5C to 70C. Each chamber holds 1 slide rack (20 slides). Includes 2 x Wash Sleeves, 1 x Slide R...
Biology Products: